Mount Sinai Innovation Partners Mount Sinai Innovation Partners Mount Sinai Innovation Partners Mount Sinai Innovation Partners
  • Get Started
    • Disclose a Technology
    • Request an Agreement
    • Search Technologies
    • Contact Your Representative
  • About Us
    • Our Mission
    • Our Impact
      • Technologies
      • Startup Companies
    • Our Team
    • Our Partners
  • Programs
    • Elementa Labs
    • Entrepreneurship Program
    • Fellows Program
    • i3 Funding
      • i3 Genesis
      • i3 Prism
      • i3 Accelerator
      • Frequently Asked Questions
    • External Collaborations
  • Resources
    • Innovation Guide
    • Drug Discovery Guide
    • Local Resources
    • IP Policy
    • Frequently Asked Questions (FAQs)
  • Discover More
    • News
    • Events
    • Videos
  • Careers
    • Explore Career Opportunities
  • Mount Sinai Health System
    • MountSinai.org
    • Search Faculty
    • Clinical Trials
    • Donations & Gifts
    • Faculty Consulting
Press Releases

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease

November 29, 2022

Risk scoring by KidneyIntelX resulted in a 4.5-fold increase in new drug prescriptions (for SGLT2 inhibitors) for high risk compared to low risk patients, an observed reduction of HbA1c levels in the highest risk patients, an overall increased use of antihypertensive therapeutics, …

Read full post
Press Releases

New Blood Test Delivers Highly Accurate Threshold Assay That Enhances Clinical Management for Peanut Allergy

September 07, 2022

Allergenis’ bead-based epitope assay at center of study from Mount Sinai revealing breakthrough diagnostic for peanut allergy. Allergenis, a predictive data analytics company specializing in the detection and management of life-threatening food allergies, today announced the results of extensive research and development …

Read full post
Press Releases

Mount Sinai Awarded $11.6 Million Grant to Launch Comprehensive Center for Surgical Innovation and Expand Mount Sinai BioDesign

August 25, 2022

Work will benefit patients, contribute to job creation and economic growth in New York City. In a move that has the potential to change the future of surgery, advance quality care, and bring economic growth to New York City, Mount Sinai Health …

Read full post
Press Releases

Mount Sinai Announces the Formation of CastleVax Inc., a Clinical-Stage Infectious Diseases Company Developing Novel Vaccines and Therapeutics, Targeting Pandemic Threats and Diseases of Unmet Medical Need

August 09, 2022

The Mount Sinai Health System in New York, NY, has launched CastleVax, Inc. (“CastleVax”), a clinical-stage vaccine research and development company. CastleVax is devoted to the commercial development of the Newcastle disease virus (NDV) vaccine platform technology originally developed in the laboratories …

Read full post
Press Releases

Gromit Therapeutics Announces an Exclusive License Agreement with the Icahn School of Medicine at Mount Sinai

June 29, 2022

Gromit Therapeutics, a clinical-stage biopharmaceutical company, developing disruptive gene therapies for inflammatory and age related diseases, and the Icahn School of Medicine at Mount Sinai in New York , NY (“Icahn Mount Sinai”) have announced today an exclusive license agreement to the …

Read full post
Press Releases

1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients

June 10, 2022

Late-breaking data presented at American Diabetes Association Scientific Sessions® demonstrates increased adherence to care guidelines for physicians using KidneyIntelX risk assessment to improve outcomes, alleviate patient suffering, and reduce significant financial burden associated with rapidly progressing chronic kidney disease. Deployment of Renalytix’s …

Read full post
Press Releases

Renalytix Announces Two Data Presentations on KidneyIntelX™ at American Diabetes Association 82nd Scientific Sessions®

June 02, 2022

Real-world clinical utility in 1,112 patients tested with KidneyIntelX. KidneyIntelX stratification for cardiovascular risk in 1,278 diabetic kidney disease patients Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced its participation at the American Diabetes Association (ADA) 82nd Scientific Sessions® meeting in New Orleans from …

Read full post
Press Releases

Mount Sinai Health System Launches i3 Prism, a Technology Commercialization Fund focused on Female and BIPOC Inventors

April 19, 2022

i3 Prism aims to bring new health care solutions to patients and society by advancing technologies from women and BIPOC inventors closer to the marketplace. Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System in New York, …

Read full post
Press Releases

Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy

April 05, 2022

Sema4 (NASDAQ: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York, NY recently published a study in Nature Communications using network modeling to identify novel …

Read full post
Press Releases

Clinical Research Associates GRITT™ Resilience-based Methodology with Significantly Reduced Healthcare Utilization and Opioid Use in Patients with IBD

January 18, 2022

Research published in Clinical Gastroenterology and Hepatology following 394 IBD patients found significantly improved outcomes with use of GRITT™ methodology, augmenting previous findings Trellus Health plc (AIM: TRLS), which is commercializing a scientifically validated, resilience-based, connected health solution for chronic condition management, …

Read full post
  • 1
  • 2
  • …
  • 7

Mount Sinai Health System

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to our local and global communities.

Read More

Contact MSIP

Mount Sinai Innovation Partners
150 East 42nd St
2nd Floor
New York, NY 10017

MSIPInfo@mssm.edu

For general inquiries: 212-659-9680

For technology and research inquiries: visit Contact Your Representative or Contact MSIP

 

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Medium

Stay Updated

Sign up for the MSIP mailing list

Mount Sinai Innovation Partners © Copyright 2023

  • Privacy Policy
  • Terms & Conditions
  • Non-Discrimination Notice
  • Get Started
    • Disclose a Technology
    • Request an Agreement
    • Search Technologies
    • Contact Your Representative
  • About Us
    • Our Mission
    • Our Impact
      • Technologies
      • Startup Companies
    • Our Team
    • Our Partners
  • Programs
    • Elementa Labs
    • Entrepreneurship Program
    • Fellows Program
    • i3 Funding
      • i3 Genesis
      • i3 Prism
      • i3 Accelerator
      • Frequently Asked Questions
    • External Collaborations
  • Resources
    • Innovation Guide
    • Drug Discovery Guide
    • Local Resources
    • IP Policy
    • Frequently Asked Questions (FAQs)
  • Discover More
    • News
    • Events
    • Videos
  • Careers
    • Explore Career Opportunities
  • Mount Sinai Health System
    • MountSinai.org
    • Search Faculty
    • Clinical Trials
    • Donations & Gifts
    • Faculty Consulting

Hit enter to search or ESC to close